Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

Denduluri Neelima; Somerfield Mark R.; Chavez-MacGregor Mariana; Comander Amy H.; Dayao Zoneddy; Eisen Andrea; Freedman Rachel A.; Gopalakrishnan Ragisha; Graff Stephanie L.; Hassett Michael J.; King Tari A.; Lyman Gary H.; Maupin Gillian Rice; Nunes Raquel; Perkins Cheryl L.; Telli Melinda L.; Trudeau Maureen E.; Wolff Antonio C.; Giordano Sharon H.

首页> 外文期刊>Journal of Clinical Oncology >Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

【24h】

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

机译：早期乳腺癌最佳辅助化疗选择和靶向治疗：ASCO指南更新

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PURPOSE The aim of this work is to update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer.

机译：目的这项工作的目的是更新ASCO指南的主要建议，以适应安大略癌症护理指南，选择早期乳腺癌最佳辅助化疗方案和乳腺癌辅助靶向治疗。

著录项

来源
《Journal of Clinical Oncology》 |2021年第6期|共11页
作者
Denduluri Neelima; Somerfield Mark R.; Chavez-MacGregor Mariana; Comander Amy H.; Dayao Zoneddy; Eisen Andrea; Freedman Rachel A.; Gopalakrishnan Ragisha; Graff Stephanie L.; Hassett Michael J.; King Tari A.; Lyman Gary H.; Maupin Gillian Rice; Nunes Raquel; Perkins Cheryl L.; Telli Melinda L.; Trudeau Maureen E.; Wolff Antonio C.; Giordano Sharon H.;
展开▼
作者单位

US Oncol Virginia Canc Specialists Arlington VA USA;

Amer Soc Clin Oncol 2318 Mill Rd Suite 800 Alexandria VA 22314 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Massachusetts Gen Hosp Ctr Newton Wellesley Newton MA USA;

Univ New Mexico Hosp Albuquerque NM USA;

Sunnybrook Odette Canc Ctr Toronto ON Canada;

Dana Farber Canc Inst Boston MA 02115 USA;

Rocky Mt Canc Ctr Colorado Springs CO USA;

HCA Midwest Hlth Sarah Cannon Canc Inst Kansas City MO USA;

Dana Farber Canc Inst Boston MA 02115 USA;

Dana Farber Canc Inst Boston MA 02115 USA;

Fred Hutchinson Canc Res Ctr 1124 Columbia St Seattle WA 98104 USA;

Virginia Hosp Ctr Arlington VA USA;

Johns Hopkins Sch Med Sidney Kimmel Canc Ctr Baltimore MD USA;

Patient Representat Dallas TX USA;

Stanford Univ Sch Med Stanford CA USA;

Sunnybrook Odette Canc Ctr Toronto ON Canada;

Johns Hopkins Sch Med Sidney Kimmel Canc Ctr Baltimore MD USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of dendritic cell/cytokine-induced killer cell immunobiological cancer therapy combined with adjuvant chemotherapy in patients with triple-negative breast cancer [J] . Ranran Zhang, Dongchu Ma, Xiaodong Xie, 中德临床肿瘤学杂志（英文版） . 2015,第001期
2. Can trastuzumab emtansine be replaced by additional chemotherapy plus targeted therapy for HER2-overexpressing breast cancer patients with residual disease after neoadjuvant chemotherapy? [J] . Juan Wu, Rong Kong, Shen Tian, 中国癌症研究（英文版） . 2019,第006期
3. Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: A prospective study [J] . 梁雪峰中国医学文摘：内科学分册（英文版） . 2013,第004期
4. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update [J] . Denduluri Neelima, Chavez-MacGregor Mariana, Telli Melinda L., Journal of Clinical Oncology . 2018,第23期

机译：选择早期乳腺癌最佳辅助化疗和靶向治疗：ASCO临床实践指南重点更新
5. Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline Summary [J] . Neelima Denduluri, Mark R. Somerfield, Antonio C. Wolff Journal of Oncology Practice . 2016,第5期

机译：早期乳腺癌最佳辅助化疗方案的选择以及HER2阳性乳腺癌的辅助靶向治疗：美国临床肿瘤学协会癌症适应指南安大略临床实践指南摘要
6. Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline [J] . Denduluri Neelima, Somerfield Mark R., Eisen Andrea, Journal of Clinical Oncology . 2016,第20期

机译：人类表皮生长因子受体2（HER2）的最佳辅助化疗方案的选择-HER2阳性乳腺癌的阴性和辅助靶向治疗：美国临床肿瘤学协会癌症适应指导委员会安大略临床实践指南的改编
7. Synergistic effects of laser and adjuvant therapies for cancer - Progress in the development of novel cancer treatment methods using combinations of photothermal, photochemical, immunotherapy and chemotherapy [C] . Wei R. Chen, Kenneth E. Bartels, Mladen Korbelik, Optical Interactions with Tissue and Cells XVI; Progress in Biomedical Optics and Imaging; vol.6, no.10 . 2005

机译：激光和辅助疗法对癌症的协同效应-结合光热，光化学，免疫疗法和化学疗法开发新型癌症治疗方法的进展
8. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
9. ASCO 2006 Update of the Breast Cancer Follow-Up and Management Guideline in the Adjuvant Setting [O] . 2006

机译：ASCO 2006辅助环境中乳腺癌随访和管理指南的更新
10. ASCO 2006 Update of the Breast Cancer Follow-Up and Management Guideline in the Adjuvant Setting [O] . 100

机译：ASCO 2006辅助环境中乳腺癌随访和管理指南的更新
11. Randomized Trial of Neuroprotective Effects of Erythropoietin in Patients Receiving Adjuvant Chemotherapy for Breast Cancer: Positron Emission Tomography and Neuropsychological Study [R] . Abraham, J. 2008

机译：促红细胞生成素对接受乳腺癌辅助化疗的患者的神经保护作用的随机试验：正电子发射断层扫描和神经心理学研究

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅